Loading stock data…
SANUWAVE Health, Inc. (SNWV)
$4.16-0.22 (-5.02%)
Market ClosedLast close Sep 8
SANUWAVE Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
SANUWAVE Health, Inc. in the Healthcare sector is trading at $4.16 with a market capitalization of $36M. The stock is currently near its 52-week low of $4.09, remaining 77.5% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. Risk note: RSI 25 is oversold, raising the odds of a near-term bounce. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 25) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $9.74M↑ | $9.62M↓ | $13.09M↑ | $11.45M↑ | $10.05M |
| Gross Profit | $7.42M | $7.43M↓ | $9.70M↑ | $8.93M↑ | $7.85M |
| Operating Income | -$280,000↑ | -$1.12M↓ | $615,000↓ | $1.47M↑ | $1.44M |
| Net Income | -$682,000↑ | -$1.44M↓ | $6.11M↓ | $10.32M↑ | $551,000 |
Peer Comparison
JNJUNHPFE
Fundamentals
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$35.79M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
5.14
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.46
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
513.56%
Volume
Today's trading volume
51,721
Recent News
SANUWAVE Health Inc (SNWV) (Q2 2026) Earnings Call Highlights: Record Applicator Sales Offset ...
Despite a 13% surge in recurring applicator revenue, the company faces headwinds from a 34% drop in system sales and proposed CMS reimbursement cuts, leading to a withdrawal of FY2026 guidance.
Sanuwave Health Q2 Earnings Call Highlights
Sanuwave Health (NASDAQ:SNWV) reported second-quarter 2026 revenue of $9.7 million, down 3% from $10.1 million a year earlier, as lower UltraMIST system sales offset continued growth in the company’s recurring applicator business. Chairman and Chief Executive Officer Morgan Frank said applicator sa
SANUWAVE Health, Inc. Q2 2026 Earnings Call Summary
Moby summary of SANUWAVE Health, Inc.'s Q2 2026 earnings call
Top Midday Decliners
Sanuwave Health's (SNWV) Q2 revenue is expected to be in the range of $8.5 million to $9.5 million,
SANUWAVE Health Inc (SNWV) Q1 2026 Earnings Call Highlights: Record Revenue Amid Market Challenges
SANUWAVE Health Inc (SNWV) reports its highest Q1 revenue ever, despite facing pricing challenges and increased operating expenses.